Fight CRC News articles

Fight Colorectal Cancer, National Cancer Institute recruit colon cancer survivors

Colon cancer non-profit works with NCI to recruit stage II and stage III colon cancer survivors for non-medicinal study. Aug. 2, 2013 - ALEXANDRIA, Va. – Fight Colorectal Cancer is working with The National Cancer Institute (NCI) to recruit participants for a new study testing informed consent documentation. Study participants will evaluate an informed consent document (ICD) that explains a clinical trial and determine its clarity and ease of use. Participants will be paid $40 for their time. The study is looking for 50 MALE SURVIVORS to participate before Aug. 31, 2013. Study results will help NCI finalize a new informed consent document for future patients considering a clinical trial. NCI chose to work

Fight Colorectal Cancer, National Cancer Institute recruit colon cancer survivors

FOR IMMEDIATE RELEASE Aug. 2, 2013 - ALEXANDRIA, Va. – Fight Colorectal Cancer is working with The National Cancer Institute (NCI) to recruit participants for a new study testing informed consent documentation. Study participants will evaluate an informed consent document (ICD) that explains a clinical trial and determine its clarity and ease of use. Participants will be paid $40 for their time. The study is looking for 50 MALE SURVIVORS to participate before Aug. 31, 2013. Study results will help NCI finalize a new informed consent document for future patients considering a clinical trial. NCI chose to work with Fight Colorectal Cancer because the ICD is written for a colon cancer clinical trial. Those

Advocacy Update: Senate Moves to Reverse Research Cuts

In February, the National Institutes of Health (NIH) Director, Francis Collins, and Senator Barbara Mikulski (D-MD) warned us of the impending impact the sequester will have on biomedical research. Francis Collins echoed Senator Mikulski’s clear warning: She stated the so-called sequestration would slow scientific progress, delay clinical trials, and put a generation of young researchers at risk if NIH’s $31 billion budget for this year is trimmed by $1.5 billion. (Quote Source: Science Insider. Feb. 21, 2013) On June 20, members of the Senate were able to show some support for cancer research funding. Led by Senator Mikulski (D-MD), the Chair of the Senate Committee on Appropriations, the committee approved a

Fight CRC Hits NYC — Summertime Planning Updates

One Million Strong is a MOVEMENT uniting those impacted by colorectal cancer. And last week – Fight Colorectal Cancer was on the MOVE. Check out what was happening amongst some of our team members as they hit New York City! Planning One Million Strong: NYC 2014 Anjee Davis, VP of Programs, and Emily White, Program Coordinator, got the wheels in motion for next year’s One Million Strong event in New York City. They met with event planning specialists at Studio PR to get the creative juices flowing. We’re excited to make next year’s event even bigger and better! Stay tuned for details on how to volunteer and get involved in

Hausmanns Raise Awareness, Funds through Softball and Horseshoes

Sometimes, love is seen through a Lady-and-the-Tramp kind of story – Italian dinners lead to sharing spaghetti and gazing into one another’s eyes. At Fight Colorectal Cancer, we have another kind of love story that gives us warm fuzzies every time we see 2013 Advocates of the Year Eric and Rose Hausmann. But instead of spaghetti dinners, the story revolves around softball. And some horseshoes. Meet the Hausmanns Many at Fight Colorectal Cancer are familiar with Rose and Eric Hausmann. They’re at the Call-on Congress year after year and chair the Grassroots Action Committee. They helped launch One Million Strong in Times Square. Rose is the cover girl for our

Don’t confuse bargain shopping with saving lives!

FIGHT COLORECTAL CANCER RESPONSE TO NEW YORK TIMES ARTICLE (6/03/2013): Fight Colorectal Cancer applauds the New York Times for shedding light on how revenue is generated by medical practices. Importantly however, the crux of the issue is not the use or overuse of colonoscopies and the variance in pricing. Rather, the main problem to be fixed in the United States is a broken fee-reimbursement structure that puts pressure on local practices and hospitals to inflate the price of reliable and needed services, like colonoscopies, to compensate for under-reimbursement for other medical services. It is unfortunate that colorectal cancer screening is used in this article as a primary example of failure

“Hope and Progress” takes an army – 30,000 of them!

As you may already have read, team members of Fight Colorectal Cancer which includes Staff, Board, Grassroots Action Committee (GAC) along with our Medical Advisory Board (MAB) have been in full swing at the Chicago 2013 Gastrointestinal Cancers Symposium. The American Society of Clinical Oncology® has been on top of their game with the distribution of material which we can barely keep up with! You can find a treasure chest of details here. This is by far the world’s largest organization of cancer specialists in one place at any time during the year. They are gathered to listen to scientific researchers present their latest findings, clinical specialists (oncologists, surgeons, radiologists,

ACA Mandates Insurance Coverage for Clinical Trials

By January 1, all insurers will be required to cover routine care for patients enrolled in clinical trials. (Typically any experimental care is provided at no cost to the patient.) “This should be seen as a step forward for the U.S. oncology community,” wrote Dr. Y-Ning Wong in the ASCO Daily News from the American Society of Clinical Oncology’s meeting in Chicago. “However, patients and providers must remain vigilant about the law’s implementation.” Currently there is a patchwork of state laws; as of January  2014, the Affordable Care Act (ACA) creates a federally required minimum that all private insurers must cover at least the usual care when patients enroll in a

Cancer Experts Gather at Chicago ASCO

With more than 30,000 members worldwide, ASCO (the American Society for Clinical Oncology) is the world’s largest organization of cancer specialists. Today in Chicago, hundreds are gathering for the annual ASCO meeting where scientific researchers present their latest findings, and clinical specialists (oncologists, surgeons, radiologists, nurses) begin to hear how the new science can be applied to their patients. Fight Colorectal Cancer is represented at ASCO by staff, Board members, and four of its Medical Advisory Board who will be presenting their own research and papers. (Watch here for reports.) “The average oncologist really needs to understand more molecular biology now than ever before,” noted Scientific Program Committee Chairman Dr. Douglas

Genetic Counselor Joins Medical Advisory Board

Long before Angelina Jolie gripped the American public’s attention by announcing her double mastectomy due to a genetic mutation, Fight Colorectal Cancer had been educating patients about family histories, plus supporting and reporting research advances in genetics—especially Lynch syndrome. One of our most reliable sources for patient information and webinars  has been Heather Hampel, MS, CGC, a genetic counselor for 18 years, and Associate Director of the Division of Human Genetics at the Ohio State University Comprehensive Cancer Center. We’re proud to announce that Heather Hampel is now an official member of our Medical Advisory Board. She first became aware of Fight Colorectal Cancer years ago when the late Kate Murphy, (one

Top